| Catasys (NASDAQ: CATS) Reports Q1 2019 Record Revenue of $6.8 Million, up 256% Year over Year and up 21% from Q4 2018 |
| |
|
Catasys (NASDAQ: CATS), a leading AI and technology-enabled healthcare company, reported its financial results for the first quarter ended March 31, 2019. The Company provides big data-based analytics and predictive modeling driven healthcare services to health plans and their members through its OnTrak™ solution.
Key Quote: “The first quarter continued the positive momentum Catasys built throughout the past year, as considerable growth in our outreach population due to expansion within our existing agreements with health plans led to strong enrollment and top line improvement during the period. Catasys continued to focus on leveraging its technological expertise to drive innovative solutions to address a wider populace, as evidenced by today’s announcement that we are expanding the use of OnTrak to help identify and address the epidemic of social isolation and loneliness, a key social determinant of health. In addition, we will continue to pursue partnerships with technology companies such as Circulation and Lyft.” Terren Peizer, Chairman and CEO
What’s Next: Company reiterates 2019 GAAP revenue guidance of $35 million.
The Backstory: Catasys harnesses proprietary big data predictive analytics, artificial intelligence and telehealth, and human intervention to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions. Catasys helps these people and their families achieve and maintain better lives.
Disclosure
Catasys (NASDAQ: CATS) is a client of RedChip Companies, Inc. CATS agreed to pay RedChip Companies, Inc. a monthly cash fee for RedChip investor awareness services and consulting services.
|
|
| |
|
| Nemaura Medical (NASDAQ: NMRD): Disrupting Multi-Billion-Dollar Markets |
| |
|
More than 100 million U.S. adults are now living with diabetes or prediabetes, according to a 2017 report from the Centers for Disease Control (CDC).
Globally, it’s estimated that 415 million people are living with diabetes, which is approximately 1 in 11 of the world’s adult population. This number is expected to rise to 642 million worldwide by 2040.
For many diabetics, monitoring and managing their disease involves constant attention and sometimes can require 10 or more finger-samples per day. This vigilant and invasive approach remains the standard of care for the majority of the world’s diabetics.
But that’s about to change.
We recently discovered a UK-based MedTech company with a non-invasive technology for remote continuous monitoring of chronic diseases and health conditions, including diabetes.
For diabetics and pre-diabetics, this innovative small-cap company has developed SugarBEAT®, a non-invasive, affordable, and flexible glucose trending device.
The global total addressable market for this technology is estimated to be worth $82 billion per annum.
And that’s just for diabetics. If pre-diabetics are included, the market size more than triples.
Near-Term Commercial Launch
Based in Loughborough, England and founded in 2013, Nemaura Medical (NASDAQ: NMRD) is expected to launch SugarBEAT® in the UK this year. Launches in key markets across Europe and beyond are anticipated to quickly follow.
Read full article at www.nmrdinfo.com
Disclosure
Nemaura Medical (NASDAQ: NMRD) is a client of RedChip Companies. NMRD agreed to pay RedChip a monthly cash fee for investor awareness services.
|
|
| |
|
| Genetic Technologies (NASDAQ: GENE) Announces New Risk Tests for Breast and Colorectal Cancers |
| |
|
Shares in Genetic Technologies (NASDAQ: GENE) nearly doubled Friday after the company announced two new ground-breaking cancer risk assessment tests had been completed and validated.
Why It Matters: Genetic Technologies is a diversified molecular diagnostics company that has already had success with cancer risk detection products that it has launched. The current tests just validated are branded as “GeneType for Colorectal Cancer” and “GeneType for Breast Cancer.” Next generation risk assessments combine multiple clinical and genetic risk factors to better stratify individuals at increased risk of developing disease.
Key Quote: “These tests allow Government Health Leaders to directly target future screening to the most high-risk patients, thereby massively reducing health system costs and providing much better outcomes for patients. GTG’s proactive approach to disease management has the potential to save both lives and money by allowing the earlier detection of disease and focusing the use of limited healthcare resources to those most in need.” Chairman and Acting CEO Dr Paul Kasian
Disclosure
Genetic Technologies (NASDAQ: GENE) is a client of RedChip Companies, Inc. GENE agreed to pay RedChip Companies, Inc. a monthly cash fee for six (6) months of RedChip investor awareness services.
|
|
| |
|
| Jefferies Weed Weekly: Key Cannabis Market News and Commentary |
| |
|
In a sector rife with daily news flow, we aim to summarize key events at the end of each week and to provide some thoughts around implications. Today we summarize a total of 22 headlines from last week. Of particular interest was Health Canada amending its cannabis licensing policy, and a story about China cashing in on the hemp/CBD boom.
Health Canada Amends Licensing Regulations
Health Canada this week announced changes to the cannabis licensing system. The changes, effective immediately, mean new applicants to cultivate, sell, or process medical cannabis must have a fully built site that meets all the requirements of the regulations at the time of their application. For existing applications, Health Canada will complete a "high level review" of whether applications can process or need more action. A major risk here is for those names who have Canadian facilities that are not yet built, as this will potentially delay projected licensing timelines, though it could also be argued as a positive, with Health Canada not reviewing redundant or speculative applications it could speed up the process for genuine applications. The other implication of these rulings for us is the possible impact on the black market. The obvious losers in this are micro producers who may not have the resources to get a reg friendly facility in place prior to licensing. It is well known that many of these micro producers are growers that are perhaps supplying the black market but want to make the effort to go legal. If they can't get licensed, they will likely just keep supplying into the black market.
China to Cash In on Hemp/CBD Boom
The New York Times published an article this week looking at the production of hemp in China. Though China has some of the strictest drug laws in the world, and cannabis legalization any time soon is very unlikely, the emerging popularity of CBD in North America and elsewhere has resulted in 2 of China's 34 regions gaining permission to extract CBD in China. China has a long history of growing hemp for industrial uses, so much of the agriculture is already in place. CBD is legal in China for use in cosmetics, but not consumption, so much of the extracted CBD is exported overseas. We have said previously that we see hemp-derived CBD production as becoming commoditized and significant price compression for non FMCG branded CBD products (well at least for those focusing on just the isolate). China becoming an exporter further supports this view.
Read full Jefferies Report
|
|
| |
|
| cbdMD (NYSE American: YCBD) to Host Conference Call to Discuss Q2 2019 Results |
| |
|
cbdMD (NYSE American: YCBD), a nationally recognized consumer cannabidiol (CBD) brand, will host a conference call at 9:00 a.m., Eastern Time, on Thursday, May 16, 2019, to discuss the company’s second quarter of fiscal year 2019 financial results and business progress.
Call Details:
Domestic: 1-877-451-6152
International: 1-201-389-0879
Replay – Available through May 30, 2019
Domestic: 1-844-512-2921
International: 1-412-317-6671
Conference ID: 13690742
Disclosure
cbdMD (NYSE American: YCBD) is a client of RedChip Companies. YCBD agreed to pay RedChip a monthly cash fee of between $5,000 and $15,000, and 5,000 shares of Rule 144 stock for RedChip investor awareness services. Additionally, the CEO of RedChip Companies owns 13,500 shares of YCBD.
|
|
| |
|
| Electra Meccanica (NASDAQ: SOLO) Reports First Quarter 2019 Financial Results |
| |
|
Electra Meccanica Vehicles Corp. (NASDAQ: SOLO), a designer and manufacturer of electric vehicles, reported its financial results for the first quarter ended March 31, 2019.
Highlights
• Commenced production of the SOLO electric vehicle at the Zongshen production facility in Chongqing, China. In the first quarter of 2019, the Company produced 20 single passenger SOLO electric vehicles at the Zongshen facility, which have all been shipped to North America.
• Completed USD$12.0 million common stock only, registered direct financing with institutional investors in March 2019 to further the design and development of the SOLO and the Tofino, as well as for general corporate purposes.
• Cash and cash equivalents and short-term deposits were CAD$30,696,299 million as of March 31, 2019, compared with CAD$18,926,933 million as of December 31, 2018.
• Total revenue for the three months ended March 31, 2019, was CAD$101,404, compared to revenue of CAD$166,133 in the same year-ago quarter. The revenue results from sales of custom cars by the Company’s subsidiary and the decrease in revenue was due to orders being put on hold for additional research and development that was being done for the eroadster.
Key Quote: “The first quarter of 2019 was marked by sustained foundation building, as we continued to prepare for the mass production ramp that we expect to take place in the second half of 2019.” Jerry Kroll, CEO of Electra Meccanica
The Backstory: Electra Meccanica is a designer and manufacturer of electric vehicles. The Company builds the innovative, all-electric SOLO, a single passenger vehicle developed to revolutionize the way people commute, as well as the Tofino, an elegant high-performance two seater electric roadster sports car. Both vehicles are tuned for the ultimate driving experience while making your commute more efficient, cost-effective and environmentally friendly. Intermeccanica, a subsidiary of Electra Meccanica, has successfully been building high-end specialty cars for 60 years. For more information, visit www.electrameccanica.com.
|
|
| |
|
| Spectrum Global (OTC: SGSI) Eliminates Over $3.6M in Convertible Debt |
| |
|
Spectrum Global Solutions (OTC: SGSI), a single-source provider of end-to-end next-generation wireless and wireline network solutions and professional services to the service provider (carrier) and corporate enterprise markets, announced that it has forced the conversion of over $3.67 million in convertible seller notes that were issued in 2017 and 2018 into Common Stock.
Why It Matters: The Common Stock was issued under Rule 144 and is subject to applicable holding periods before it may be sold. The effect of the conversion was to not only reduce debt and accrued interest but increase our shareholder net equity as we prepare for a NASDAQ up listing application. For further details, please refer to our Current Report on Form 8-K which will be filed with the Securities and Exchange Commission.
Key Quote: “These seller notes have had a toxic impact on our stock price in recent months as portions of the notes were sold at a discount to face value and then converted into common stock at a discount to the market price. This forced conversion not only eliminated the ability of the holder to do that in the future, but the notes were actually converted at a substantial premium to the current market price.” – Roger Ponder, CEO
The Backstory: Spectrum Global Solutions operates through its subsidiaries, AW Solutions, ADEX Corp and TNS. The Company is a leading provider of telecommunications engineering and infrastructure services across the United States, Canada, Puerto Rico, Guam and Caribbean. For more information about the Company and its technologies, visit the Company’s public filings at www.SEC.gov or the Company’s website at SpectrumGlobalSolutions.com
Disclosure
Spectrum Global Solutions (OTCQB: SGSI) is a client of RedChip Companies, Inc. SGSI agreed to pay RedChip Companies, Inc. a monthly cash fee for six (6) months of RedChip investor awareness services.
|
|
| |
|
| eMARINE Global (OTC: EMRN) Receives New Orders from Hanjin Heavy Industries |
| |
|
eMARINE Global (OTC: EMRN), a leading provider of information and communications technology (ICT) for the maritime industry, signed a contract with Hanjin Heavy Industries & Construction (HHIC) to supply the Company’s Warship Electronic Chart Display & Information System (WECDIS) to two ROK Navy multi-purpose training boats (MTBs).
Why It Matters: This latest contract award is for the third and fourth MTBs in the series. Previously, the Company was awarded and installed its WECDIS technology on the first two MTBs, and both boats are now in training operations. The current contract is valued at 100 million won ($85,000 USD). HHIC is one of the top yards for specialty ships, including naval vessels.
Key Quote: “We continue to dominate the Korean defense market. eMARINE currently provides technology maintenance services for 215 ROK Navy ships under an annual contract agreement, and we continue to strive to strengthen our leading position in servicing the Navy and other key customers.” Ung Gyu Kim, Chairman and CEO
Disclosure
eMARINE Global (OTC: EMRN) is a client of RedChip Companies. RedChip Companies, Inc. owns 613,000 shares of EMRN common stock.
|
|
| |
|
| |
| Quote of the Week |
| |
"Look at what you can afford to lose, it's a numbers game"
- Manager of MidSouth Investor Fund |
|
|
|
|
|
|
|
| About RedChip |
| |
| RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. |
| |
| RedChip Disclosure |
| |
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures. |
|
| |
|
|
| |
|
|
Copyright © 2019 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.
|
|
|
|
|
|
